✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
首页 › 产品目录 › 吉姆扎尔

吉姆扎尔

CAS 122111-03-9C9H12ClF2N3O4MW 299.66

吉姆扎尔(CAS 122111-03-9)属医药中间体及原料药类产品,分子式 C9H12ClF2N3O4,分子量 299.66。济南圣和化工有限公司常年现货供应该产品,常规纯度 按批次COA提供(不公开发布),可按客户需求安排分装包装,欢迎邮件或来电询价。

产品概览

CAS号122111-03-9
分子式C9H12ClF2N3O4
分子量299.66
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域医药中间体及原料药
类别医药中间体及原料药

应用领域

医药中间体及原料药

吉姆扎尔主要应用于医药中间体及原料药。具体使用工况下的添加量与规格要求,欢迎与技术团队沟通确认。

包装与储存

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
运输常规化工运输
样品可协商提供
交期现货/按订单安排

供应说明:吉姆扎尔 常规包装为按订单/批次确认(不公开发布),储存时应密封置于阴凉干燥处,避免与氧化剂混放。济南圣和化工有限公司 支持国内物流发货,大货交期与运费以订单确认为准。

质量与文件

每批产品随货提供 COA(分析证书);可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

济南圣和化工有限公司位于山东济南,主营化工原料供应,精选产品 3,000+ 种,覆盖有机化学品、无机化学品、食品添加剂、医药中间体等 12 大分类。我们随货提供 COA 分析证书,一个工作日内回复报价,欢迎国内外采购方长期合作。

常见问题

吉姆扎尔 的 CAS 号是多少?

吉姆扎尔 的 CAS 号为 122111-03-9。

该产品的纯度和包装规格是什么?

常规纯度规格为 按批次COA提供(不公开发布),包装为 按订单/批次确认(不公开发布),随货提供 COA。

吉姆扎尔 有什么用途?

主要应用于医药中间体及原料药。

如何购买或获取报价?

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系,注明产品名称、CAS 号与需求数量,一个工作日内回复报价。供应商:济南圣和化工有限公司。

PubChem 公开数据

Description

Gemcitabine Hcl · CAS 122111-03-9 · C9H12ClF2N3O4. UNII U347PV74IL.

Identification

CAS Registry Number122111-03-9
PubChem CID60749
Molecular formulaC9H12ClF2N3O4
IUPAC name4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride
UNII (FDA)U347PV74IL

Computed Descriptors

Molecular Weight299.66
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count6
Rotatable Bond Count2
Exact Mass299.0484399
Monoisotopic Mass299.0484399
Topological Polar Surface Area108
Heavy Atom Count19
Formal Charge0
Complexity426

GHS Hazard Classification

Reported hazard statementsH302 (11.3%), H312 (25.8%), H315 (12.9%), H319 (30.6%), H340 (25.8%), H360 (85.5%), H361 (11.3%)

H302 (11.3%): Harmful if swallowed [Warning Acute toxicity, oral]

H312 (25.8%): Harmful in contact with skin [Warning Acute toxicity, dermal]

Documented Uses

  • Gemcitabine hydrochloride is approved to be used alone or with other drugs to treat:
  • • Breast cancer that cannot be treated with or that did not respond to chemotherapy that included an anthracycline drug. It is used with paclitaxel as the first therapy for cancer that has spread to other parts of the body.
  • • Non-small cell lung cancer. It is used with cisplatin in patients whose cancer is stage IIIA, stage IIIB, or stage IV.
  • • Ovarian cancer that is advanced and has relapsed at least 6 months after treatment with platinum chemotherapy. It is used with carboplatin.
  • • Pancreatic cancer. It is used alone in patients whose cancer is stage II or stage III and cannot be removed by surgery or stage IV. It is used in patients whose cancer has been treated with fluorouracil.
  • Gemcitabine hydrochloride is also being studied in the treatment of other types of cancer.

Synonyms

GEMCITABINE HYDROCHLORIDE; 122111-03-9; Gemcitabine HCl; LY188011 hydrochloride; 2'-Deoxy-2',2'-difluorocytidine monohydrochloride; 2'-deoxy-2',2'-difluorocytidine hydrochloride; INFUGEM; Gemcitabine (as hydrochloride); Cytidine, 2'-deoxy-2',2'-difluoro-, monohydrochloride; DTXSID3047849; Gemcitabine HCI; U347PV74IL; LY-188011 HYDROCHLORIDE; 2',2'-Difluorodeoxycytidine monohydrochloride; DTXCID3027827; NSC613327

Frequently Asked Questions

What are the CAS number and molecular formula of Gemcitabine Hcl?

CAS 122111-03-9; molecular formula C9H12ClF2N3O4; molecular weight — g/mol.

What other names is Gemcitabine Hcl known by?

GEMCITABINE HYDROCHLORIDE, 122111-03-9, Gemcitabine HCl, LY188011 hydrochloride, 2'-Deoxy-2',2'-difluorocytidine monohydrochloride, 2'-deoxy-2',2'-difluorocytidine hydrochloride.

Is Gemcitabine Hcl classified as hazardous?

Hazard statements reported: H302, H312, H315, H319, H340.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

获取报价

✉ info@591daili.com☎ +86-18553102138📞 WhatsApp邮件询价WhatsApp 询价

供应商:济南圣和化工有限公司

鲁ICP备19031700号-2